Adiponectin, a unique adipocyte-derived factor beyond hormones.
暂无分享,去创建一个
[1] Mike Henne. And three's a party: lysosomes, lipid droplets, and the ER in lipid trafficking and cell homeostasis. , 2019, Current opinion in cell biology.
[2] T. Funahashi,et al. Adiponectin promotes muscle regeneration through binding to T-cadherin , 2019, Scientific Reports.
[3] M. Copetti,et al. Circulating adiponectin levels are paradoxically associated with mortality rate. A systematic review and meta-analysis. , 2018, The Journal of clinical endocrinology and metabolism.
[4] Hitoshi Nishizawa,et al. Low muscle quality in Japanese type 2 diabetic patients with visceral fat accumulation , 2018, Cardiovascular Diabetology.
[5] E. Fukusaki,et al. Adiponectin/T-cadherin system enhances exosome biogenesis and decreases cellular ceramides by exosomal release. , 2018, JCI insight.
[6] V. Trischitta,et al. The Adiponectin Paradox for All-Cause and Cardiovascular Mortality , 2017, Diabetes.
[7] T. Funahashi,et al. The unique prodomain of T-cadherin plays a key role in adiponectin binding with the essential extracellular cadherin repeats 1 and 2 , 2017, The Journal of Biological Chemistry.
[8] T. Funahashi,et al. Significant Association of Serum Adiponectin and Creatine Kinase-MB Levels in ST-Segment Elevation Myocardial Infarction , 2017, Journal of atherosclerosis and thrombosis.
[9] P. Scherer,et al. Inducible overexpression of adiponectin receptors highlight the roles of adiponectin-induced ceramidase signaling in lipid and glucose homeostasis , 2017, Molecular metabolism.
[10] T. Funahashi,et al. Adiponectin association with T‐cadherin protects against neointima proliferation and atherosclerosis , 2017, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[11] S. Kihara,et al. Marked elevation of serum M2BP-adiponectin complex in men with coronary artery disease. , 2016, Atherosclerosis.
[12] M. Copetti,et al. The combined effect of adiponectin and resistin on all-cause mortality in patients with type 2 diabetes: Evidence of synergism with abdominal adiposity. , 2016, Atherosclerosis.
[13] Li-Ling Wu,et al. Circulating adiponectin levels in various malignancies: an updated meta-analysis of 107 studies , 2016, Oncotarget.
[14] Clotilde Théry,et al. Communication by Extracellular Vesicles: Where We Are and Where We Need to Go , 2016, Cell.
[15] S. De Cosmo,et al. The paradoxical association of adiponectin with mortality rate in patients with type 2 diabetes: evidence of synergism with kidney function. , 2016, Atherosclerosis.
[16] R. Nagatomi,et al. High circulating adiponectin levels predict decreased muscle strength among older adults aged 70 years and over: A prospective cohort study. , 2015, Nutrition, metabolism, and cardiovascular diseases : NMCD.
[17] S. Yokoyama,et al. Crystal structures of the human adiponectin receptors , 2015, Nature.
[18] T. Funahashi,et al. Positive feedback regulation between adiponectin and T-cadherin impacts adiponectin levels in tissue and plasma of male mice. , 2015, Endocrinology.
[19] Antoine b.. La différenciation sexuelle , 2014 .
[20] S. Yoshida,et al. Adiponectin attenuates abdominal aortic aneurysm formation in hyperlipidemic mice. , 2014, Atherosclerosis.
[21] Yukiko Nakamura,et al. Ultrastructural Localization of Adiponectin protein in Vasculature of Normal and Atherosclerotic mice , 2014, Scientific Reports.
[22] M. Quon,et al. Modulation of adiponectin as a potential therapeutic strategy. , 2014, Atherosclerosis.
[23] K. Kohara,et al. CDH13 Genotype–Dependent Association of High–Molecular Weight Adiponectin With All-Cause Mortality: The J-SHIPP Study , 2014, Diabetes Care.
[24] Y. Teo,et al. Genetic Variation in CDH13 Is Associated With Lower Plasma Adiponectin Levels but Greater Adiponectin Sensitivity in East Asian Populations , 2013, Diabetes.
[25] A. Sahebkar,et al. Fibrate therapy and circulating adiponectin concentrations: a systematic review and meta-analysis of randomized placebo-controlled trials. , 2013, Atherosclerosis.
[26] S. Kihara,et al. Adiponectin Protein Exists in Aortic Endothelial Cells , 2013, PloS one.
[27] P. Low,et al. Choroid plexus transcytosis and exosome shuttling deliver folate into brain parenchyma , 2013, Nature Communications.
[28] Ryosuke Kikuchi,et al. T-cadherin Is Essential for Adiponectin-mediated Revascularization* , 2013, The Journal of Biological Chemistry.
[29] T. Funahashi,et al. Correlation between serum C1q-adiponectin/total adiponectin ratio and polyvascular lesions detected by vascular ultrasonography in Japanese type 2 diabetics. , 2013, Metabolism: clinical and experimental.
[30] C. Mantzoros,et al. Associations of Total and High-Molecular-Weight Adiponectin With All-Cause and Cardiovascular Mortality in Older Persons: The Cardiovascular Health Study , 2012, Circulation.
[31] A. Gabrielsen,et al. High plasma adiponectin concentration is associated with all-cause mortality in patients with carotid atherosclerosis. , 2012, Atherosclerosis.
[32] F. Clavel-Chapelon,et al. Total and high-molecular weight adiponectin and risk of colorectal cancer: the European Prospective Investigation into Cancer and Nutrition Study. , 2012, Carcinogenesis.
[33] Y. Kokubo,et al. CDH13 gene coding t‐cadherin influences variations in plasma adiponectin levels in the Japanese population , 2012, Human mutation.
[34] M. Whooley,et al. Adiponectin is associated with increased mortality and heart failure in patients with stable ischemic heart disease: data from the Heart and Soul Study. , 2012, Atherosclerosis.
[35] Wen-Harn Pan,et al. A Genome-Wide Association Study Reveals a Quantitative Trait Locus of Adiponectin on CDH13 That Predicts Cardiometabolic Outcomes , 2011, Diabetes.
[36] P. Wilson,et al. Adiponectin: an independent risk factor for coronary heart disease in men in the Framingham offspring Study. , 2011, Atherosclerosis.
[37] T. Lehtimäki,et al. A longitudinal analysis on associations of adiponectin levels with metabolic syndrome and carotid artery intima-media thickness. The Cardiovascular Risk in Young Finns Study. , 2011, Atherosclerosis.
[38] S. Kihara,et al. Dynamic Changes of Adiponectin and S100A8 Levels by the Selective Peroxisome Proliferator–Activated Receptor-&ggr; Agonist Rivoglitazone , 2011, Arteriosclerosis, thrombosis, and vascular biology.
[39] P. Ruiz-Lozano,et al. T-cadherin is critical for adiponectin-mediated cardioprotection in mice. , 2010, The Journal of clinical investigation.
[40] C. Hug,et al. Impact of adiponectin deficiency on pulmonary responses to acute ozone exposure in mice. , 2010, American journal of respiratory cell and molecular biology.
[41] M. Matsuzaki,et al. Correlation between circulating adiponectin levels and coronary plaque regression during aggressive lipid-lowering therapy in patients with acute coronary syndrome: subgroup analysis of JAPAN-ACS study. , 2010, Atherosclerosis.
[42] K. Walsh,et al. Effects of adiponectin deficiency on structural and metabolic remodeling in mice subjected to pressure overload. , 2010, American journal of physiology. Heart and circulatory physiology.
[43] J. Skepper,et al. Differential Mechanisms of Shedding of the Glycosylphosphatidylinositol (GPI)-anchored NKG2D Ligands* , 2010, The Journal of Biological Chemistry.
[44] S. Kihara,et al. Blockade of mineralocorticoid receptor reverses adipocyte dysfunction and insulin resistance in obese mice. , 2009, Cardiovascular research.
[45] Feng Liu,et al. Yin-Yang Regulation of Adiponectin Signaling by APPL Isoforms in Muscle Cells* , 2009, The Journal of Biological Chemistry.
[46] W. Zhou,et al. LKB1 is required for adiponectin-mediated modulation of AMPK–S6K axis and inhibition of migration and invasion of breast cancer cells , 2009, Oncogene.
[47] J. Baynes,et al. Succination of Thiol Groups in Adipose Tissue Proteins in Diabetes , 2009, The Journal of Biological Chemistry.
[48] T. Funahashi,et al. Natriuretic peptides enhance the production of adiponectin in human adipocytes and in patients with chronic heart failure. , 2009, Journal of the American College of Cardiology.
[49] A. Iyama,et al. A cross-sectional study for glucose intolerance of myotonic dystrophy , 2009, Journal of the Neurological Sciences.
[50] Feng Liu,et al. A disulfide-bond A oxidoreductase-like protein (DsbA-L) regulates adiponectin multimerization , 2008, Proceedings of the National Academy of Sciences.
[51] H. Parving,et al. Serum adiponectin predicts all-cause mortality and end stage renal disease in patients with type I diabetes and diabetic nephropathy. , 2008, Kidney international.
[52] B. Suki,et al. Alveolar macrophage activation and an emphysema-like phenotype in adiponectin-deficient mice. , 2008, American journal of physiology. Lung cellular and molecular physiology.
[53] M. Christ-Crain,et al. Increase in high molecular weight adiponectin by bariatric surgery‐induced weight loss , 2008, Diabetes, obesity & metabolism.
[54] S. Kihara,et al. Adiponectin Protects Against Angiotensin II–Induced Cardiac Fibrosis Through Activation of PPAR-&agr; , 2008, Arteriosclerosis, thrombosis, and vascular biology.
[55] B. Falkner,et al. Adiponectin regulates albuminuria and podocyte function in mice. , 2008, The Journal of clinical investigation.
[56] E. Tuzcu,et al. Comparison of pioglitazone vs glimepiride on progression of coronary atherosclerosis in patients with type 2 diabetes: the PERISCOPE randomized controlled trial. , 2008, JAMA.
[57] Petra Schwille,et al. Ceramide Triggers Budding of Exosome Vesicles into Multivesicular Endosomes , 2008, Science.
[58] A. Xu,et al. Post-translational modifications of adiponectin: mechanisms and functional implications. , 2008, The Biochemical journal.
[59] S. Kihara,et al. Adiponectin accumulates in myocardial tissue that has been damaged by ischemia-reperfusion injury via leakage from the vascular compartment. , 2007, Cardiovascular research.
[60] Hong Wang,et al. Adiponectin Secretion Is Regulated by SIRT1 and the Endoplasmic Reticulum Oxidoreductase Ero1-Lα , 2007, Molecular and Cellular Biology.
[61] P. Froguel,et al. Targeted disruption of AdipoR1 and AdipoR2 causes abrogation of adiponectin binding and metabolic actions , 2007, Nature Medicine.
[62] D. Tanné,et al. Effects of Peroxisome Proliferator-Activated Receptor Ligands, Bezafibrate and Fenofibrate, on Adiponectin Level , 2007, Arteriosclerosis, thrombosis, and vascular biology.
[63] S. Kihara,et al. Adiponectin modulates inflammatory reactions via calreticulin receptor-dependent clearance of early apoptotic bodies. , 2007, The Journal of clinical investigation.
[64] L. Risch,et al. Relationship between glomerular filtration rate and the adipokines adiponectin, resistin and leptin in coronary patients with predominantly normal or mildly impaired renal function. , 2007, Clinica chimica acta; international journal of clinical chemistry.
[65] T. Ogihara,et al. Adiponectin and renal function, and implication as a risk of cardiovascular disease. , 2006, The American journal of cardiology.
[66] G. Beck,et al. Adiponectin and mortality in patients with chronic kidney disease. , 2006, Journal of the American Society of Nephrology : JASN.
[67] A. Xu,et al. Adiponectin attenuates allergen-induced airway inflammation and hyperresponsiveness in mice. , 2006, The Journal of allergy and clinical immunology.
[68] P. Verkade,et al. Alzheimer's disease beta-amyloid peptides are released in association with exosomes. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[69] Feng Liu,et al. APPL1 binds to adiponectin receptors and mediates adiponectin signalling and function , 2006, Nature Cell Biology.
[70] W. Willett,et al. Low plasma adiponectin levels and risk of colorectal cancer in men: a prospective study. , 2005, Journal of the National Cancer Institute.
[71] Jan Frystyk,et al. Plasma Adiponectin, Body Mass Index, and Mortality in Patients With Chronic Heart Failure , 2005, Circulation.
[72] J. Couzin. The Ins and Outs of Exosomes , 2005, Science.
[73] C. Forsblom,et al. Serum adiponectin is increased in type 1 diabetic patients with nephropathy. , 2005, Diabetes care.
[74] Morihiro Matsuda,et al. Increased oxidative stress in obesity and its impact on metabolic syndrome. , 2004, The Journal of clinical investigation.
[75] S. Kihara,et al. Adiponectin-mediated modulation of hypertrophic signals in the heart , 2004, Nature Medicine.
[76] H. Lodish,et al. T-cadherin is a receptor for hexameric and high-molecular-weight forms of Acrp30/adiponectin. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[77] W. Faigle,et al. Cells release prions in association with exosomes. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[78] Ming-Ming Zhou,et al. Structure of the neural (N-) cadherin prodomain reveals a cadherin extracellular domain-like fold without adhesive characteristics. , 2004, Structure.
[79] Cynthia J. Girman,et al. Plasma adiponectin levels and risk of myocardial infarction in men. , 2004, JAMA.
[80] T. Ogihara,et al. Adiponectin I164T mutation is associated with the metabolic syndrome and coronary artery disease. , 2004, Journal of the American College of Cardiology.
[81] S. Kihara,et al. Enhanced carbon tetrachloride-induced liver fibrosis in mice lacking adiponectin. , 2003, Gastroenterology.
[82] P. Froguel,et al. Impaired Multimerization of Human Adiponectin Mutants Associated with Diabetes , 2003, Journal of Biological Chemistry.
[83] S. Toubro,et al. Regulation of adiponectin by adipose tissue-derived cytokines: in vivo and in vitro investigations in humans. , 2003, American journal of physiology. Endocrinology and metabolism.
[84] M. Matsuda,et al. Induction of adiponectin, a fat-derived antidiabetic and antiatherogenic factor, by nuclear receptors. , 2003, Diabetes.
[85] Yu Wang,et al. The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice. , 2003, The Journal of clinical investigation.
[86] Philippe Froguel,et al. Cloning of adiponectin receptors that mediate antidiabetic metabolic effects , 2003, Nature.
[87] S. Kihara,et al. Erratum , 2003, Heart.
[88] M. Cnop,et al. Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex , 2003, Diabetologia.
[89] J. Engel,et al. Structure-Function Studies of the Adipocyte-secreted Hormone Acrp30/Adiponectin , 2003, The Journal of Biological Chemistry.
[90] R. Paschke,et al. Adiponectin gene expression and secretion is inhibited by interleukin-6 in 3T3-L1 adipocytes. , 2003, Biochemical and biophysical research communications.
[91] S. Kihara,et al. Association of Hypoadiponectinemia With Coronary Artery Disease in Men , 2003, Arteriosclerosis, thrombosis, and vascular biology.
[92] R. A. Norman,et al. The effect of thiazolidinediones on plasma adiponectin levels in normal, obese, and type 2 diabetic subjects. , 2002, Diabetes.
[93] M. Matsuda,et al. Androgens decrease plasma adiponectin, an insulin-sensitizing adipocyte-derived protein. , 2002, Diabetes.
[94] Jonathan Krakoff,et al. Adiponectin and development of type 2 diabetes in the Pima Indian population , 2002, The Lancet.
[95] M. Matsuda,et al. Association of adiponectin mutation with type 2 diabetes: a candidate gene for the insulin resistance syndrome. , 2002, Diabetes.
[96] S. Kihara,et al. Adipocyte-Derived Plasma Protein Adiponectin Acts as a Platelet-Derived Growth Factor-BB–Binding Protein and Regulates Growth Factor–Induced Common Postreceptor Signal in Vascular Smooth Muscle Cell , 2002, Circulation.
[97] M. Matsuda,et al. Diet-induced insulin resistance in mice lacking adiponectin/ACRP30 , 2002, Nature Medicine.
[98] M. Matsuda,et al. PPARgamma ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein. , 2001, Diabetes.
[99] Y. Terauchi,et al. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity , 2001, Nature Medicine.
[100] H. Lodish,et al. Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice. , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[101] S. Kihara,et al. Adiponectin, a new member of the family of soluble defense collagens, negatively regulates the growth of myelomonocytic progenitors and the functions of macrophages. , 2000, Blood.
[102] T Nakamura,et al. Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. , 2000, Arteriosclerosis, thrombosis, and vascular biology.
[103] T Nakamura,et al. Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin. , 1999, Circulation.
[104] T Nakamura,et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. , 1999, Biochemical and biophysical research communications.
[105] L. Olson,et al. Mouse glycosylphosphatidylinositol-specific phospholipase D (Gpld1) characterization , 1998, Mammalian Genome.
[106] Philipp E. Scherer,et al. The crystal structure of a complement-1q family protein suggests an evolutionary link to tumor necrosis factor , 1998, Current Biology.
[107] Y. Matsuzawa,et al. Analysis of an expression profile of genes in the human adipose tissue. , 1997, Gene.
[108] Y. Nakano,et al. Isolation and characterization of GBP28, a novel gelatin-binding protein purified from human plasma. , 1996, Journal of biochemistry.
[109] S. Yamashita,et al. Enhanced expression of PAI–1 in visceral fat: Possible contributor to vascular disease in obeisty , 1996, Nature Medicine.
[110] B. Spiegelman,et al. AdipoQ Is a Novel Adipose-specific Gene Dysregulated in Obesity (*) , 1996, The Journal of Biological Chemistry.
[111] T. Funahashi,et al. cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (AdiPose Most abundant Gene transcript 1). , 1996, Biochemical and biophysical research communications.
[112] Philipp E. Scherer,et al. A Novel Serum Protein Similar to C1q, Produced Exclusively in Adipocytes (*) , 1995, The Journal of Biological Chemistry.
[113] T Nakamura,et al. Contribution of visceral fat accumulation to the development of coronary artery disease in non-obese men. , 1994, Atherosclerosis.
[114] Y. Matsuzawa,et al. Pathophysiology and Pathogenesis of Visceral Fat Obesity , 1993, Annals of the New York Academy of Sciences.
[115] B. Ranscht,et al. T-cadherin, a novel cadherin cell adhesion molecule in the nervous system lacks the conserved cytoplasmic region , 1991, Neuron.
[116] J. Vague. Sexual differentiation; Factor determining forms of obesity. , 1947 .
[117] T. Funahashi,et al. Binding of adiponectin and C1q in human serum, and clinical significance of the measurement of C1q-adiponectin / total adiponectin ratio. , 2013, Metabolism: clinical and experimental.
[118] M. Birnbaum,et al. Receptor-mediated activation of ceramidase activity initiates the pleiotropic actions of adiponectin , 2011, Nature Medicine.
[119] Y. Matsuzawa,et al. Contribution of intra-abdominal fat accumulation to the impairment of glucose and lipid metabolism in human obesity. , 1987, Metabolism: clinical and experimental.
[120] Y. Matsuzawa,et al. A novel technique for the determination of body fat by computed tomography. , 1983, International journal of obesity.